2C or not 2C: phenethylamine designer drug review. - Wikidata - wikimedia - TriplyDB

2C or not 2C: phenethylamine designer drug review.

2C or not 2C: phenethylamine designer drug review.

http://www.wikidata.org/entity/Q38089682

about

Neuropharmacology of New Psychoactive Substances (NPS): Focus on the Rewarding and Reinforcing Properties of Cannabimimetics and Amphetamine-Like Stimulants Psychedelics and Immunomodulation: Novel Approaches and Therapeutic Opportunities Designer drugs 2015: assessment and management.NBOMe and 2C substitute phenylethylamine exposures reported to the National Poison Data System.Analysis of 25I-NBOMe, 25B-NBOMe, 25C-NBOMe and Other Dimethoxyphenyl-N-[(2-Methoxyphenyl) Methyl]Ethanamine Derivatives on Blotter Paper.Behavioral and neurochemical pharmacology of six psychoactive substituted phenethylamines: mouse locomotion, rat drug discrimination and in vitro receptor and transporter binding and function.High-performance liquid chromatography with tandem mass spectrometry for the determination of nine hallucinogenic 25-NBOMe designer drugs in urine specimens.2-(4-Iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOMe): clinical case with unique confirmatory testing.Postmortem detection of 25I-NBOMe [2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine] in fluids and tissues determined by high performance liquid chromatography with tandem mass spectrometry from a traumatic death.Determination of 4-bromo-2,5-dimethoxy-N-[(2-methoxyphenyl)methyl]-benzeneethanamine (25B-NBOMe) in serum and urine by high performance liquid chromatography with tandem mass spectrometry in a case of severe intoxication."Not for human consumption": a review of emerging designer drugs.2C-I-NBOMe, an "N-bomb" that kills with "Smiles". Toxicological and legislative aspects.What Can a Urine Drug Screening Immunoassay Really Tell Us?Pharmacology and Toxicology of N-Benzylphenethylamine ("NBOMe") Hallucinogens.Stereoselective inhibition of serotonin transporters by antimalarial compounds.Novel Psychoactive Substances-Recent Progress on Neuropharmacological Mechanisms of Action for Selected Drugs.Evaluation of the Abuse Potential of Novel Amphetamine Derivatives with Modifications on the Amine (NBNA) and Phenyl (EDA, PMEA, 2-APN) Sites.Characterization of hallucinogenic phenethylamines using high-resolution mass spectrometry for non-targeted screening purposes.Detection of 25C-NBOMe in Three Related Cases.Comparative neuropharmacology of N-(2-methoxybenzyl)-2,5-dimethoxyphenethylamine (NBOMe) hallucinogens and their 2C counterparts in male rats.25B-NBOMe and its precursor 2C-B: modern trends and hidden dangers

P2860

Q26752739-06C2D37F-2898-4601-9C8D-ADC59284CBCF Q26799997-31F26528-F468-4A73-93FF-A3DDF821A041 Q30300017-B3E85A2A-AC98-4CED-8B7F-8A64DE04C5B7 Q30969880-DFA9C316-B4C8-4D54-952C-27FE38115B4B Q36062676-A5DF464F-2633-40B8-AD9D-7D0B40E5320A Q37622283-C5BCC614-8AEF-4BC6-A076-07C25F1B4972 Q37630040-333C74F4-496A-459E-97D5-6D26F6D69AB0 Q37633498-9DC2F162-31B7-4575-88B2-2A6620E3B930 Q37672302-26123192-AA8A-407E-9266-30D2C62CE6A8 Q37728569-069EC828-450F-440E-ABBF-2F37225CD8D6 Q38202898-9B450887-63B6-4915-88F2-6CABC6BFCD5B Q38208426-464F78AF-6FE4-48EF-811C-70967EFCB8CE Q38444921-7A40401F-E9C1-459A-91C5-32BD6A938726 Q39093171-180D219D-54BD-46B2-9EB2-E0926A98629A Q41364370-7C9C1F42-55D2-4B45-9638-89431A66C4E9 Q41462770-3A74F108-7338-4599-A41E-8429AFC5212B Q47137534-B700E089-A6C9-4937-9C35-0F1B62B025A8 Q48299643-D5D447EF-54E8-40A6-93B8-C495C4DD0376 Q48721685-067940E6-C3C2-4F71-B1F8-C6C187487565 Q53080749-9ACB06BC-24E1-489D-A097-BC7DAFB7915F Q59218493-64C70C1E-7636-4385-8AE8-93EA02600E73

P2860

2C or not 2C: phenethylamine designer drug review.

http://www.wikidata.org/entity/Q38089682

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

2C or not 2C: phenethylamine designer drug review.

@en

type

label

2C or not 2C: phenethylamine designer drug review.

@en

prefLabel

2C or not 2C: phenethylamine designer drug review.

@en

P1433

Q38089682-1CC0C8ED-5B88-4CF3-BE1A-C5062757FA48

P1476

Q38089682-12E7027F-19B6-4AC1-ACBC-DBFED65DD368

P2093

Q38089682-3C7776C2-B99E-4EAA-B3FC-566F90059884

Q38089682-44E3E7CA-F8AC-4BF4-8DC7-79FC0D653A98

Q38089682-D533CAF5-BD9F-4A90-A65B-B575625CEFBF

P2860

Q38089682-0813C33F-B82C-4113-83C2-885758F95D98

Q38089682-1978B11B-2F0F-4A0C-9FCD-FD2FF8AF8F07

Q38089682-21194E97-FDF9-4A34-AE13-BAB7B69B4FC2

Q38089682-33856AE6-0447-42B1-8055-2B6F226FA80F

Q38089682-36313AE0-6C87-4280-A347-E7EFEAFE81DB

Q38089682-3B5777E6-C2E5-4568-BFFC-D71C0C52D946

Q38089682-4B25F7D9-128A-459D-B749-209D90736472

Q38089682-59A2EEEE-4970-432B-8666-D9AF5DF66983

Q38089682-59F3BAFE-BDBC-4C9E-A9AA-24D5A8870881

Q38089682-5A081541-71DE-4F69-B9FE-CAA1309415E9

P2888

Q38089682-EBD8E161-6EA7-4BA6-90D7-7781DEA9C0D2

P304

Q38089682-713EDB0A-7EE1-439E-BAE6-3072F1685C25

P31

Q38089682-08498151-9D21-4EB1-9D2B-9D79B1D5DA4E

P356

Q38089682-0DD870A4-C7D6-4DD7-91A6-650C1184B559

P433

Q38089682-17B328EB-B91D-4466-B7E2-CBBE810DFA26

P478

Q38089682-5FE48EE9-E8E8-4E7C-9A05-AAB1E3947FDB

P50

Q38089682-7B7A6282-9F38-473B-9DB7-101083293A67

P577

Q38089682-285A95FE-6313-4A3B-9C93-5EE303EB9BE9

P5875

Q38089682-8FA7E8FF-4CA1-4E4E-9EE8-F2B47646076C

P6179

Q38089682-B2718787-D084-4F0B-8471-FA71517F91CF

P698

Q38089682-14497BD8-B3C1-4E05-830F-69BB97CCB729

P932

Q38089682-653640DA-F857-432E-B527-1E36AA8EEB67

P356

S13181-013-0295-X

P1433

Journal of Medical Toxicology

P1476

2C or not 2C: phenethylamine designer drug review

@en

P2093

Aaron M Burnett

http://www.w3.org/2001/XMLSchema#string

Be Vang Dean

http://www.w3.org/2001/XMLSchema#string

Kristin M Engebretsen

http://www.w3.org/2001/XMLSchema#string

P2860

Selective loss of dopamine D3-type receptor mRNA expression in parietal and motor cortices of patients with chronic schizophrenia

4-Bromo-2,5-dimethoxyphenethylamine (2C-B) and structurally related phenylethylamines are potent 5-HT2A receptor antagonists in Xenopus laevis oocytes

The effects of non-medically used psychoactive drugs on monoamine neurotransmission in rat brain

Dihydrobenzofuran analogues of hallucinogens. 3. Models of 4-substituted (2,5-dimethoxyphenyl)alkylamine derivatives with rigidified methoxy groups

"Research chemicals": tryptamine and phenethylamine use among high-risk youth.

Chemistry, pharmacology, and metabolism of emerging drugs of abuse.

Excited Delirium Syndrome (ExDS): defining based on a review of the literature.

4-Bromo-2,5-dimethoxyphenethylamine (2C-B): a review of the public domain literature.

Excited delirium

Metabolic pathways of 4-bromo-2,5-dimethoxyphenethylamine (2C-B): analysis of phase I metabolism with hepatocytes of six species including human.

P2888

s13181-013-0295-x

P304

172-178

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S13181-013-0295-X

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

Samuel J Stellpflug

P577

2013-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236049264

http://www.w3.org/2001/XMLSchema#string

P6179

1033931165

http://www.w3.org/2001/XMLSchema#string

P698

23494844

http://www.w3.org/2001/XMLSchema#string

P932

3657019

http://www.w3.org/2001/XMLSchema#string